News
EKTAF
5.88
NaN%
--
Elekta AB Non-GAAP EPS of SEK 0.69, revenue of SEK 3.54B; reaffirms full-year outlook
Seeking Alpha · 08/27 08:50
Elekta Non-GAAP EPS of SEK 0.57, revenue of SEK 4.76B; gives fiscal year 2026/27 outlook
Seeking Alpha · 05/28 07:49
Elekta AB: Tricky, But With A Latent Upside
Seeking Alpha · 05/19 14:58
Elekta AB reports Q3 results
Seeking Alpha · 03/05 18:58
Elekta AB reports Q2 results
Seeking Alpha · 11/26/2025 13:07
Elekta AB Non-GAAP EPS of SEK 0.64, revenue of SEK 4.07B; reaffirms FY outlook
Seeking Alpha · 11/26/2025 12:24
Accuray's Latest Transformation Attempt Could Be Too Little Too Late
Seeking Alpha · 11/06/2025 17:35
More
Webull provides a variety of real-time EKTAF stock news. You can receive the latest news about Elekta Ab through multiple platforms. This information may help you make smarter investment decisions.
About EKTAF
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.